SPECIFIC PHARMA A/S
CVR: 33161395
Secondary names: Specific Care A/S
The financial health of SPECIFIC PHARMA A/S appears robust, with a notable upward trajectory in both revenue and profit over the past few years. Revenue increased from 123.3 million DKK in 2022 to 219.3 million DKK in 2025, while profit rose significantly from 7.8 million DKK to 29.2 million DKK in the same period, indicating strong operational efficiency and market demand. The company's equity has also improved, reaching 111.2 million DKK, which reflects a solid capital position. However, the fluctuating profit margins and lack of a CDS score may raise concerns regarding financial stability. Overall, SPECIFIC PHARMA A/S is well-positioned within the pharmaceutical wholesale industry, demonstrating growth potential and increasing profitability.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er - direkte eller via besiddelse af kapitalandele i andre selskaber - at drive handel med og tilbyde serviceydelser inden for sundhedsområdet samt anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 219.3 mio. | 29.2 mio. | 134.5 mio. | 111.2 mio. | 28 | |
History
Ownership
Management
Directors
Board
Founders
Production units (1)
Similar companies
Companies in the same industry and area